About Genotypic
Genotypic is a company based in Bengaluru (India) founded in 1998. Genotypic has raised $171.23 thousand across 1 funding round from investors including Sadanand Bopat and Anuja Vivek Joshi. The company has 82 employees. Genotypic offers products and services including Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services. Genotypic operates in a competitive market with competitors including Helix, Strand Life Sciences, Benchling, Genuity Science and Inpharmatica, among others.
- Headquarter Bengaluru, India
- Employees 82
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website genotypic.co.in
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Genotypic Technology Private Limited
- Date of Incorporation 09 Oct, 1998
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹39.04 Cr
FY 2025 · -25% YoY
- Net Profit₹60.2 Lakh
FY 2025 · 2% margin
- EBITDA₹2.38 Cr
FY 2025 · 6% margin
- Total Equity Funding$171.23K (USD)
in 1 rounds
- Latest Funding Round$171.23K (USD), Angel Round
Mar 2006
- Employee Count82
Associated legal entities of Genotypic
Genotypic operates through Genotypic Technology Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genotypic Technology Private Limited CIN U72200KA1998PTC049038 | Active | 09 Oct 1998 | Bangalore, Karnataka | ₹39.0 Cr | 82 | 2 | View details |
Products & Services of Genotypic
Genotypic offers a comprehensive portfolio of products and services, including Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services.
Tool for simplifying NGS data analysis and processing.
Provides DNA sequencing using Nanopore technology.
Offers gene expression analysis and profiling services.
Delivers integrated data analysis for genomic projects.
Apps and channels of Genotypic
its YouTube channel Genotypic Technology has 122 subscribers and 24 videos.
Videos from Genotypic
The most watched videos on Genotypic's YouTube channel, Genotypic Technology (122 subscribers). Click a video to play it here.
More on Genotypic Technology.
Funding Insights of Genotypic
Genotypic has successfully raised a total of $171.23K through 1 strategic funding round. The most recent funding activity was a Angel Round of $171.23 thousand completed in March 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $171,233
- Total Rounds 1
- Last Round Angel Round — $171,233
- First Round $171,233
(Mar 2006)
- Investors Count 2
All 1 funding rounds of Genotypic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2006 | $171,233 | Angel Round | $381,260 | Sadanand Bopat, Anuja Vivek Joshi | – |
Last known valuation $381,260 (Mar 2006). 2 investors in total: 0 institutional and 2 angel.
Investors in Genotypic
Genotypic has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Sadanand Bopat and Anuja Vivek Joshi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SB Sadanand Bopat | - | – | unknown_05b4149c6a074c5cb | - |
AV Anuja Vivek Joshi | - | – | unknown_2704f0cd81f84be18 | - |
Investor details for Genotypic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genotypic Technology Private Limited (Genotypic)
Genotypic Technology Private Limited is the primary company behind Genotypic. The board of Genotypic Technology Private Limited currently have 2 directors; the longest-serving is Raja Chinnadurai Mugasimangalam, appointed in 1998. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raja Chinnadurai Mugasimangalam DIN 01907491 | Managing Director | 09 Oct 1998 | 28 yrs | Genotypic Technology Private Limited |
| Sudha Narayan Rao DIN 01726325 | Whole-time director | 29 Sep 1999 | 27 yrs | Genotypic Technology Private Limited |
Financials of Genotypic
Figures of Genotypic Technology Private Limited, the primary company behind Genotypic, for FY 2025. Revenue was ₹39.04 Cr (-25% year on year). Net profit was ₹60.2 Lakh (2% margin). EBITDA was ₹2.38 Cr (6% margin). Revenue has grown at a compounded annual rate of +11% over three years and +22% over five years.
- ₹39.04 CrRevenue · FY 2025 · -25% YoY
- ₹60.2 LakhNet profit · 2% margin
- ₹2.38 CrEBITDA · 6% margin
- ₹25.8 LakhPaid-up capital
- 82Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genotypic Technology Private Limited are on its company page.
Detailed financial statements for Genotypic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Genotypic
2 dated milestones of Genotypic across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Genotypic is founded.
- Funding First funding round of $171K.
Competitors of Genotypic
Genotypic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Strand Life Sciences, Benchling, Genuity Science and Inpharmatica, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| strandls.com | 2000 | Bengaluru, India | $34.88M | 532 | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| icarbonx.com | 2015 | Shenzhen, China | $365.68M | – | Bioinformatics platforms are provided for health management and drug development. | |
| cellworks.life | 2005 | San Jose, United States | $16.52M | – | Biosimulation platform developed for therapeutic design in life sciences. |
Detailed competitors of Genotypic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genotypic
The website of Genotypic (genotypic.co.in) receives about 6.3K visits a month and ranks #2,782,867 among all websites worldwide, #3,746 in Biotechnology and Pharmaceuticals.
- Monthly visits6.3K
▲ 0.7% vs previous month
- Unique visitors3.2K
per month
- Global rank#2,782,867
among all websites
- Category rank#3,746
Health · Biotechnology and Pharmaceuticals
- Bounce rate26%
- Pages per visit2.4
- Average visit1 min 51 sec
- DevicesDesktop 11% · Mobile 89%
Websites whose visitors overlap most with Genotypic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genomica.es | 100% | – | – | View details | |
bioarray.es | bioarray.es | 61% | – | #8,434,475 | – |
Similar companies to Genotypic
10 companies that operate in the same segment as Genotypic (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genotypic
Genotypic was founded in 1998 and raised its 1st funding round 8 years after it was founded.
Genotypic is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Genotypic is a funded company, having raised a total of $171.23K across 1 funding round to date. The company's 1st funding round was a Angel Round of $171.23K, raised on Mar 2006.
Genotypic has 82 employees.
The primary company behind Genotypic, Genotypic Technology Private Limited, reported revenue of ₹39.04 Cr for FY 2025, down 25% year on year.
Provider of genomics and bioinformatics services. It provides genomic analysis using microarrays, next-generation sequencing (NGS), and bioinformatics services and solutions to domesticinternational pharma, biotech companies, and academia. The company has six products which include catalog microarrays, Biointerpreter which is a web-based biological interpretation tool for microarrays, Medrunner which extracts relevant information from PubMed abstracts, PubMine that extracts relevant information from MedLine abstracts, SeqQC for quality control and reporting of NGS data, and BioIT for IT solutions.
Genotypic's top competitors include Strand Life Sciences, Helix and Benchling.
Genotypic offers Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services.
Genotypic has 2 investors. Key investors include Sadanand Bopat, and Anuja Vivek Joshi.
The valuation of Genotypic is $381.26K as of Mar 2006.
Genotypic operates through Genotypic Technology Private Limited.
The legal entities of Genotypic currently have 2 directors, including Raja Chinnadurai Mugasimangalam, Sudha Narayan Rao.